{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "RCTs comparing fibrinolytic agents to treat peripheral arterial occlusion."
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "RCTs comparing fibrinolytic agents to treat peripheral arterial occlusion."
      },
      "Objective": {
        "score": 1,
        "evidence": "To determine which fibrinolytic agents are most effective in peripheral arterial ischaemia."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Five RCTs involving a total of 687 participants with a range of clinical indications were included."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "vessel patency was greater with intra\u2010arterial recombinant tissue plasminogen activator (rt\u2010PA) than with intra\u2010arterial streptokinase (P < 0.04) or intravenous rt\u2010PA (P < 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Incidences of haemorrhagic complications varied with fibrinolytic regime but there was no statistically significant difference between intra\u2010arterial urokinase and intra\u2010arterial rt\u2010PA."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 8,
    "max_score": 25
  },
  "model": "gpt-4o"
}